Cryoport Systems, formerly known as Cell&Co, is a leading player in the biopharma, biotechnology, and health care industries. As a subsidiary of Cryoport Systems, the company specializes in expert GMP products management and clinical sample management. It offers a comprehensive solution for handling GMP products and biological samples, including storage, packaging, traceability, and trusted logistic services. Established in 2012, Cell&Co BioServices is the first and most important French private biorepository, known for its recognized, certified, and regulatory authorized operations with the highest and unmatched capacity. The company operates two GMP plants and provides mirroring storage capacities ranging from -196°C to +20°C. The company's services include GMP products management, secure storage for cell banks, DS, DP, and cold chain logistics, as well as biobanking for R&D samples and clinical sample management, which encompasses sampling kits, logistics flows, monitoring, and processing with qualified third-party laboratories. Cell&Co and Cryoport are deeply engaged in innovative technical solutions and IT tools to enhance traceability and quality for clients' samples and products. With their mission to provide reliable and comprehensive solutions, the company can be reached at [email protected].
There is no investment information
No recent news or press coverage available for Cryoport Systems (formerly Cell&Co).